Skip to content
Lower risk Drug recall · FDA · Published December 2, 2019

AuroMedics Moxifloxacin Eye Drops Recall: Discoloration Risk

AuroMedics recalls 0.5% Moxifloxacin eye drops due to discoloration complaints. Affected lots from India with specific expiration dates. Stop using if discoloration occurs.

🇺🇸 FDA recall #D-0789-2020DrugAuroMedics ›
Take action

Contact the company

Recalling firmAuroMedics Pharma LLC279 Princeton Hightstown Rd · East Windsor, NJ 08520-1401
✎ GovInfoNow plain-language explainer

AuroMedics is recalling certain moxifloxacin eye drops because customers reported discoloration. This could affect eye health if the solution is used improperly. Read more at govinfonow.com/recall/37666-auromedics-moxifloxacin-eye-drops-recall-discoloration-risk.

Source Summary by GovInfoNow · govinfonow.com/recall/37666-auromedics-moxifloxacin-eye-drops-recall-discoloration-risk · Updated October 5, 2026 · FDA enforcement record: FDA #D-0789-2020

Cite this page

“AuroMedics Moxifloxacin Eye Drops Recall: Discoloration Risk.” GovInfoNow, updated October 5, 2026. https://govinfonow.com/recall/37666-auromedics-moxifloxacin-eye-drops-recall-discoloration-risk. Based on FDA recall #D-0789-2020 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0789-2020%22&limit=1).

AuroMedics Pharma LLC, distributed by Aurobindo Pharma USA, Inc., recalled Moxifloxacin Ophthalmic Solution USP on Dec. 2, 2019, after complaints of discoloration, the FDA said. The voluntary Class III recall affects 100,080 bottles sold nationwide.

How to tell if you have it

  • Brand: AuroMedics
  • Product: Moxifloxacin Ophthalmic Solution USP, 0.5%, Sterile, 3mL Bottle
  • NDC: 65862-840-03
  • Lot codes: CMF190008 (Exp. 04/2021), CMF190009 (Exp. 04/2021), CMF190025 (Exp. 06/2021), CMF190026 (Exp. 06/2021)
  • Quantity: 100,080 bottles

The hazard

The recall was initiated due to market complaints regarding discoloration in the Moxifloxacin Ophthalmic Solution. The FDA classified this as a Class III recall.

Context

GovInfoNow's records show AuroMedics Pharma LLC has 22 other recalls on record since Dec. 4, 2017. Other recent recalls of similar products include Imprimis Dexamethasone Moxifloxacin Eye Drops Recall (Dec. 18, 2025), Clear Eyes Eye Drops Recall (Sept. 15, 2026), and Apotex Brimonidine/Timolol Eye Drops Recall (March 5, 2026).

How to tell if you have this one

Check for discoloration in the 3mL bottle labeled Moxifloxacin Ophthalmic Solution 0.5%. The product was distributed with specific lot numbers and expiration dates.

  • Brand
    AuroMedics
  • Category
    Drug
Based on the official FDA remedy

What to do — step by step

  1. Check for Discoloration

    Inspect the eye drop solution for any discoloration before use.

Where it went and when

Where it was distributed

Distributed nationwide.

Alaska: yesAKMaine: yesMEVermont: yesVTNew Hampshire: yesNHWashington: yesWAIdaho: yesIDMontana: yesMTNorth Dakota: yesNDMinnesota: yesMNIllinois: yesILWisconsin: yesWIMichigan: yesMINew York: yesNYRhode Island: yesRIMassachusetts: yesMAOregon: yesORNevada: yesNVWyoming: yesWYSouth Dakota: yesSDIowa: yesIAIndiana: yesINOhio: yesOHPennsylvania: yesPANew Jersey: yesNJConnecticut: yesCTCalifornia: yesCAUtah: yesUTColorado: yesCONebraska: yesNEMissouri: yesMOKentucky: yesKYWest Virginia: yesWVVirginia: yesVAMaryland: yesMDDelaware: yesDEArizona: yesAZNew Mexico: yesNMKansas: yesKSArkansas: yesARTennessee: yesTNNorth Carolina: yesNCSouth Carolina: yesSCDistrict of Columbia: yesDCOklahoma: yesOKLouisiana: yesLAMississippi: yesMSAlabama: yesALGeorgia: yesGAHawaii: yesHITexas: yesTXFlorida: yesFL

FDA distribution: “Nationwide in the U.S.” States read from FDA’s own wording; “not listed” means the notice does not name it.

Distributed nationwide.

Recall timeline

FDA terminated this recall 3 years after the firm started it.

1. Firm started the recall: Dec 2, 201912. FDA classified it Class III: Jan 17, 202023. Published in FDA’s Enforcement Report: Jan 22, 202034. FDA terminated the recall: Nov 22, 2022420192022
  1. Firm started the recall
  2. FDA classified it Class III
  3. Published in FDA’s Enforcement Report
  4. FDA terminated the recall

Dates from the agency record only; steps without a date are left out.

✎ GovInfoNow

Questions people ask

Is this product safe to use?

The recall is due to discoloration complaints, not safety issues. If the solution appears normal, it may be safe to use as directed.

What should I do if I have discoloration?

Stop using the product immediately and contact your doctor for advice.

How can I tell if I have the recalled product?

Look for the 3mL bottle with lot numbers CMF190008, CMF190009, CMF190025, or CMF190026, and expiration dates of 04/2021 or 06/2021.

Similar recalls

Latest drug recalls

Keep exploring

Where this comes from

The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.

  • Official source: FDA Recall #D-0789-2020 (December 2, 2019) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0789-2020 to see it in context.
  • Plain-language summary written by qwen3:4b on October 5, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
  • GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.
GovInfoNow is an independent guide. We are not FDA or any government agency. Always confirm details with the official recall.Data: CPSC · FDA · NHTSA · USDA